© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
797772 |
| Generic Name | Procaterol Hydrochloride |
| Chemical Formula | C16H22N2O3·HCl |
| Drug Class | Beta-2 adrenergic agonist |
| Molecular Weight | 326.82 g/mol (anhydrous base) |
| Cas Number | 79617-96-2 |
| Route Of Administration | Oral, Inhalation |
| Indications | Asthma, Chronic obstructive pulmonary disease (COPD) |
| Mechanism Of Action | Relaxation of bronchial smooth muscle by beta-2 receptor stimulation |
| Appearance | White to off-white crystalline powder |
| Storage Conditions | Store at room temperature, protected from light and moisture |
As an accredited Procaterol Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Procaterol Hydrochloride is packaged in a white, tamper-evident bottle containing 100 tablets, each clearly labeled with strength and batch number. |
| Shipping | Procaterol Hydrochloride is shipped in compliance with applicable chemical safety regulations. It is securely packaged in sealed containers, protected from moisture and light, and labeled according to hazardous materials guidelines. Temperature control and appropriate documentation are ensured to maintain product integrity and regulatory compliance during transit. Handle with caution upon receipt. |
| Storage | Procaterol Hydrochloride should be stored in a tightly closed container, protected from light and moisture. It should be kept at room temperature, typically between 15°C and 30°C (59°F and 86°F). Avoid exposure to extreme heat, freezing, or direct sunlight. Store in a secure location away from incompatible substances, following local regulations for chemical storage. |
|
Purity 99.5%: Procaterol Hydrochloride with purity 99.5% is used in pharmaceutical formulations, where it ensures high efficacy and consistent bronchodilatory response. Molecular Weight 322.2 g/mol: Procaterol Hydrochloride with molecular weight 322.2 g/mol is used in respiratory therapy research, where it enables precise dosage calculations for targeted airway relaxation. Particle Size D90 <10 µm: Procaterol Hydrochloride with particle size D90 <10 µm is used in dry powder inhaler preparations, where it improves pulmonary deposition and rapid onset of action. Stability Temperature up to 40°C: Procaterol Hydrochloride with stability temperature up to 40°C is used in long-term storage studies, where it maintains chemical integrity and therapeutic potency. Water Content ≤0.5%: Procaterol Hydrochloride with water content ≤0.5% is used in sterile injectable solutions, where it minimizes hydrolytic degradation and increases formulation shelf life. Melting Point 143–146°C: Procaterol Hydrochloride with melting point 143–146°C is used in process optimization during tablet manufacturing, where it facilitates controlled granulation without decomposition. Residual Solvent Level <50 ppm: Procaterol Hydrochloride with residual solvent level <50 ppm is used in compliance testing for regulatory submissions, where it meets international safety standards for pharmaceuticals. |
Competitive Procaterol Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Medicines shape the way countless people breathe every day. Among those medicines, procaterol hydrochloride stands out for people who live with wheezing, shortness of breath, and the struggles that come with asthma or chronic obstructive pulmonary disease (COPD). This isn’t just chemistry in a bottle; it represents stability, quality, and a chance for easier days. I’ve talked to healthcare colleagues, read through clinical guidelines, and dug into what sets this medicine apart. Let’s talk about why procaterol hydrochloride makes a difference, where it works best, and what anyone considering it should know.
Procaterol hydrochloride comes as a bronchodilator, which means it helps open up airways, letting people breathe more freely. The air tube muscles relax, letting more oxygen in and making coughing or tightness less severe. Every pharmacy I’ve worked with stocks bronchodilators, but few hold up with the reliable rapid action that procaterol brings. Many patients report a noticeable improvement in breathing not long after their dose. For the right patient, this isn’t a subtle change—it can mean the difference between a restless night and a peaceful sleep.
Most people encounter procaterol hydrochloride through oral tablets or syrup, but metered-dose inhalers (MDIs) are also available in places where they meet regulatory approval. The choice between these forms really hinges on individual needs. Some folks prefer the immediate, on-the-go relief of inhalers, especially during exercise or sudden symptom flare-ups. Others lean on syrups and tablets for routine, steady control.
Tablets usually come in measured doses, often around 25 micrograms or so per unit, though strength and specifications can shift depending on where you buy them. Syrups tend to make dosing for children easier, a point many parents have shared with me in clinic settings. Inhalers offer fast, targeted relief, but they require a certain dexterity and understanding, which can be tough for some. Everyone’s story is different, but this variety means almost anyone with the right diagnosis can find a form that fits their life.
The world of bronchodilators is crowded: salbutamol, terbutaline, formoterol, and more. Each carries strengths and quirks. Procaterol hydrochloride belongs to a class known as beta2-adrenergic agonists. This technical tag just means it triggers the body to relax airway muscles, opening them wide. People who have bounced from one medicine to another often tell me procaterol brings them comfort with fewer unwanted side effects—like jitteriness or racing heartbeats—compared to some other quick-acting bronchodilators.
One of the most practical ways it stands apart is its duration of action. It’s not as fleeting as some short-acting inhalers, nor does it demand the slow, drawn-out build-up of long-acting drugs. In clinical terms, procaterol sits nicely in the middle, offering sustained symptom control through much of the day. The dosing schedule, which might be twice daily, means fewer interruptions—an underrated benefit when life gets busy.
Asthma and COPD sideline millions. These conditions aren’t picky; they reach into homes everywhere, across all ages and backgrounds. Young athletes, older adults, city dwellers, and rural families all know what it’s like to feel the sudden panic of a blocked airway. Treatment options matter because no single medicine fits everyone. I’ve seen patients find relief with procaterol after struggling on others, finally catching their breath about it. Outcomes hinge on access to flexible, reliable medicines, and that’s where procaterol earns its reputation.
Clinical trials and long-term patient follow-ups point out real advantages. A study published in an established respiratory journal found measurable improvement in peak flow values for patients taking procaterol hydrochloride compared with a control group. The frequency of nighttime complaints, which disrupt sleep for families everywhere, dropped, and reported day-to-day wellbeing ticked up. Having spent time in clinics, I’ve watched parents’ relief as their child wakes up smiling, not coughing.
No medicine works alone. The story of procaterol hydrochloride ties closely to patient understanding, regular check-ups, and support from doctors or pharmacists. Most side effects tend to be mild if the medicine is used as prescribed. Some report trembling hands, a feeling of nervousness, or a sense that their heartbeat quickens. I always advise open conversations about any concerns, as sometimes side effects result from an incorrect dose or conflicts with other medicines. Regular check-ins prevent small issues from becoming real problems.
Manufacturers shape the quality of procaterol hydrochloride. From sourcing raw ingredients to testing each batch, a reliable supply means peace of mind for patients and healthcare providers alike. Adulteration or uneven dosages can upend trust, so reputable suppliers play a major role in patient safety. When patients ask, I urge them to stick with products from sources their pharmacists recommend, and to keep each medicine in its own original packaging.
Salbutamol often tops lists for short-acting bronchodilation, and it works fast. But many users feel “buzzed” or uncomfortably stimulated after a dose. For some, especially kids or older folks, these feelings can be worse than asthma itself. Procaterol hydrochloride often causes less agitation, giving much-needed relief without adding new discomforts. It also holds its own in terms of duration, with a steady effect lasting for several hours.
Formoterol is another beta2-agonist, but it tends to stick around even longer. That long effect suits certain use cases, but it’s not always the right fit for sudden, unexpected attacks needing fast breathing relief. The middle ground that procaterol occupies opens options for tailored asthma and COPD plans, something both doctors and patients appreciate. In practice, a prescriber may combine it with preventive medicines, customizing care in ways that fit individual lifestyles.
Procaterol hydrochloride steps up for people who can’t tolerate side effects from other bronchodilators. It also serves children who have trouble using inhalers, since syrup forms make dosing easy. Busy adults who want predictable, lasting relief from airway tightness rely on its twice-daily schedule to keep symptoms in check without repeatedly returning to the medicine cabinet. In my experience, it holds a strong place for those managing mild to moderate symptoms and anyone in need of a bridge between fast relief and routine maintenance.
It forms part of treatment plans shaped by years of research and frontline experiences. Modern guidelines include procaterol in their toolkits, recognizing its unique value. The measure of medicine goes beyond chemical structure—it rests in lived patient stories, in parents able to send their kids outside, and in older folks who can climb a flight of stairs again.
Even the best products face obstacles reaching those who need them. In some regions, regulatory hurdles mean procaterol hydrochloride doesn’t always line pharmacy shelves. Drug shortages, cost factors, and supply chain hiccups add complication, especially for families already stretched thin. Access gaps force some people to settle for less effective or riskier medicines.
The cost of treatment can also weigh on decision-making. Insurance plans, national formularies, and availability in local clinics directly impact who gets which medicine. For some families, choosing between daily essentials and reliable treatment forces painful decisions. Community health workers and patient advocates play an important role here by guiding patients to available assistance programs and identifying stable sources for needed treatment.
Addressing these barriers calls for a blend of effort—policy changes, public health initiatives, and better support for both providers and patients. Policies that smooth regulation and boost competition often lower prices and open up supply lines. In my experience, when health authorities develop clear formularies with transparent pricing, patients win. Reliable information about sourcing, fair pricing from pharma companies, and robust health worker training all combine to build trust and ensure safe use.
On the frontline, education changes outcomes. Many people don’t know how to properly use inhalers or measure liquid doses at home. Pharmacists, after all, serve as a first line of information for practical medicine use. Community workshops, one-on-one sessions, and printed guides in clinics help people build confidence with their medicine, which drives better results.
Technology offers a boost, too. Simple text message reminders, online health portals, or even basic mobile apps can help patients remember doses and report worrisome side effects. My colleagues have seen real improvements in asthma control just by setting up these support systems, even in clinics with basic resources. When families stay closely connected to care teams, they spot problems early and stay on track.
Nothing replaces the lessons drawn from ongoing research and real-world feedback. Doctors, patients, and scientists keep learning by sharing experiences and insights. Regular reviews of treatment guidelines—grounded in data from studies and case reports—help keep the use of procaterol hydrochloride current and safe. This process shapes smarter, safer, and more effective care.
Pharmaceutical manufacturers can also play a part in supporting ongoing trials and publishing transparent results. Honest reporting of both benefits and risks earns patient and provider trust. Reliable medicines only work when communities feel safe taking them. Ongoing safety monitoring and easy reporting for adverse events mean problems show up fast, so fixes can follow. Every medicine story grows with real patient voices and shared data—not faceless marketing promises.
Standing at the center of many treatment plans, procaterol hydrochloride already helps thousands breathe easier, sleep better, and take part in daily life with less worry. The challenge now lies in reaching those still left out. Fair pricing, more consistent supplies, and broader education form the next steps. I’ve seen firsthand that results improve most when all players—drug makers, doctors, pharmacists, community leaders, and families—work together for better care.
The move toward more personalized medicine will only raise the importance of reliable, flexible therapies like procaterol hydrochloride. As doctors gather more information about individual patients—genetics, lifestyle, environment—they can fit symptom control to each case. That’s good news not just for asthma and COPD patients, but for anyone ready to focus on living, not just managing a diagnosis.
From my early days on a hospital ward to the years spent in community clinics, I’ve watched medicines become lifelines for families. Procaterol hydrochloride earns its place not because it’s the newest or flashiest, but because it works consistently in real situations. Teachers, parents, athletes, and retirees depend on simple, timely solutions so they can focus on what matters. The steady hands of the people who manufacture, prescribe, and distribute these medicines matter just as much as the science behind the label.
For those trying to understand whether procaterol hydrochloride fits their needs, nothing beats direct conversation with a trusted healthcare provider. Remember to bring questions to your pharmacy or doctor’s office, share concerns about side effects, or ask about affordable access. And if you’re a health professional reading this, never underestimate the value of a medicine explained well, a dose tailored carefully, and a follow-up call after a rough night.
At its core, the story of procaterol hydrochloride grows with each person who relies on it. I’ve heard the relief in parents’ voices after their child’s cough fades, the calm from patients who can finally walk without stopping for breath. These are more than testimonials; they’re reminders that medicine isn’t about faceless conditions—it’s about making today brighter and tomorrow possible.
So much of medicine boils down to trust. Trust in the people who recommend, prepare, and supply the medicines that line pharmacy shelves. Trust that the right product will arrive on time and at a fair price. Procaterol hydrochloride’s reputation grows from decades of use, thousands of prescriptions filled, and millions of breaths eased. Its track record continues to inspire confidence—and constant vigilance for safety, access, and new improvements.
Procaterol hydrochloride stands on many legs: science, experience, patient voices, and the dedication of health professionals. As other drugs come and go from the market, as studies grow and guidelines shift, this medicine’s middle-ground profile keeps it a steady player in asthma and COPD care. Through careful stewardship, open dialogue, and continued research, its value in the lives of people everywhere only expands.
If you’re facing respiratory symptoms, have questions about asthma treatment, or want to know more about bronchodilator options, seek out conversation with someone who knows your health story. In the end, every medicine—from the simplest pill to advanced inhalers—works best when it fits the life of the person holding it.
